Barrick Gold Corp vs Medpace Holdings Inc — how do they compare? Barrick Gold Corp trades at $40.13 (market cap $65.92B), while Medpace Holdings Inc trades at $597.39 (market cap $16.90B). The key difference: Barrick Gold Corp is far larger — about 3.9× Medpace Holdings Inc's market cap, and Barrick Gold Corp pays a 1.74% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| B | MEDP | |
|---|---|---|
Market Cap | $65.92B | $16.90B |
Sector | Basic Materials | Technology |
52-Week High | $52.97 | $620.59 |
52-Week Low | $23.50 | $393.42 |
Enterprise Value | $64.67B | $16.52B |
Dividend Yield | 1.74% | — |
Signals from Pluang's Aura AI — not financial advice
Barrick Mining (B) trades at $41.56, up 1.59% with strong bullish momentum. The stock shows robust fundamentals with a P/E of 10.37, net income margin of 31.6%, and consistent earnings beats. Recent developments include a $1.95 billion settlement with Newmont and plans for a North American gold IPO, driving positive sentiment. Technical indicators show bullish moving averages with support at $40 and resistance at $41.
Outlook remains positive with 66.7% analyst buy ratings and a $49.83 consensus target, offering 20% upside. Key risks include gold price volatility and execution of the IPO. Strong cash flow growth and debt reduction support the bullish case, though investors should monitor commodity price trends and operational execution.
MEDP trades at $600.00, down 0.4% on the day, with a bullish technical signal driven by moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $4.25, and raised full-year guidance. Revenue growth is robust, with 2026 projected at $2.8 billion, though valuation multiples like a P/E of 35.58 and P/B of 38.95 are elevated. Net cash flow is expected to turn positive in 2026, and institutional activity is mixed, with some funds increasing stakes while others trim positions.
Outlook is positive due to earnings momentum and record bookings, but risks include high valuation sensitivity and a shareholder lawsuit investigation. Analyst consensus is a $599.57 price target with a 'Hold' bias, suggesting limited near-term upside from current levels amid growth-priced expectations.
Trailing returns across standard periods
Latest headlines on both assets
Barrick Gold Corp is one of the world's largest gold producers, operating mines in North America, South America, Australia, and Africa. The company segments consist of nine gold mines namely Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, and Bulyanhulu. It generates maximum revenue from the Carlin mine segment. Geographically, it derives a majority of revenue from the United States.
Read more on B →Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →